Abacavir
- Product NDC
- 31722-562
- 11-digit product format
- 317220562
- Labeler code
- 31722
- Product ID
- 31722-562_34da1f28-8687-4286-a674-ac3cb61440f5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA201107
- Marketing category
- ANDA
- Marketing start
- 2016-09-26
- Substance
- ABACAVIR SULFATE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Abacavir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ABACAVIR SULFATE | 20 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J220T4J9Q2 |
| Rxcui | 242680 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-562-24 | Abacavir | 240 mL in 1 BOTTLE | SOLUTION | 240 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 31722-562 | ABACAVIR SOLUTION [CAMBER PHARMACEUTICALS, INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20170925_e5cbf204-c10d-444b-aba0-180a30645d55.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 31722-562-24 | 31722056224 | 240 mL in 1 BOTTLE (31722-562-24) | 240 ml | 2016-09-26 | 0000-00-00 | No | No | Current |